1.Photodynamic Therapy for Barrett's Esophagus and Esophageal Carcinoma.
Bashar J QUMSEYA ; Waseem DAVID ; Herbert C WOLFSEN
Clinical Endoscopy 2013;46(1):30-37
This paper reviews the use of photodynamic therapy (PDT) in patients with Barrett's esophagus and esophageal carcinoma. We describe the history of PDT, mechanics, photosensitizers for PDT in patients with esophageal disease. Finally, we discuss its utility and limitations in this setting.
Aminolevulinic Acid
;
Barrett Esophagus
;
Dihematoporphyrin Ether
;
Esophageal Diseases
;
Esophageal Neoplasms
;
Humans
;
Mechanics
;
Photochemotherapy
;
Photosensitizing Agents
;
Triazenes
2.Trends in Utilization of Preoperative Embolization for Spinal Metastases: A Study of the National Inpatient Sample 2005–2017
Waseem WAHOOD ; Alex Yohan ALEXANDER ; Yagiz Ugur YOLCU ; Waleed BRINJIKJI ; David F. KALLMES ; Giuseppe LANZINO ; Mohamad BYDON
Neurointervention 2021;16(1):52-58
Purpose:
While previous studies have suggested that preoperative embolization of hypervascular spinal metastases may alleviate intraoperative blood loss and improve resectability, trends and driving factors for choosing this approach have not been extensively explored. Therefore, we evaluated the trends and assessed the factors associated with preoperative embolization utilization for spinal metastatic tumors using a national inpatient database.
Materials and Methods:
The National Inpatient Sample database of the Healthcare Cost and Utilization Project was queried for patients undergoing surgical resection for spinal metastasis between January 1, 2005 and December 31, 2017. Patients undergoing preoperative embolization were identified; trends in the utilization of preoperative embolization were analyzed using the Cochran-Armitage test. Multivariable regression was conducted to assess factors associated with higher preoperative embolization utilization.
Results:
A total of 11,508 patients with spinal metastasis were identified; 105 (0.91%) underwent preoperative embolization. Of those 105 patients, 79 (75.24%) patients had a primary renal cancer, as compared to 1,732 (15.19%) of those who did not undergo preoperative embolization (P<0.001). The majority of patients in the non-preoperative embolization cohort had a primary lung tumor (n=3,562, 31.24%). Additionally, patient comorbidities were similar among the 2 groups (P>0.05). Trends in preoperative embolization indicated an increase of 0.16% (standard error: 0.024%, P<0.001) in utilization per year.
Conclusion
Utilization of preoperative embolization for spinal metastasis is increasing yearly, especially for patients with renal cancer, suggesting that surgeons may increasingly consider embolization before surgical resection for hypervascular tumors. Additionally, the literature has shown the intraoperative and postoperative benefits of this procedure.